Relationship between the Maternal-Fetal Complications and the Severity of HELLP Syndrome, Classified based on Maternal Platelet Count Nadir.
- Author:
Man Chul PARK
1
;
Seung Hun LEE
;
Jun Young IM
;
Hyun Jun KIM
;
Kyoung Soon KWON
;
Choong Hak PARK
Author Information
1. Department of Obstetrics and Gynecology, Dankook University College of Medicine, Cheonan, Korea.
- Publication Type:Original Article
- Keywords:
HELLP syndrome
- MeSH:
Alanine Transaminase;
Aspartate Aminotransferases;
Birth Weight;
Blood Platelets*;
Eclampsia;
Female;
Gestational Age;
HELLP Syndrome*;
Humans;
Incidence;
L-Lactate Dehydrogenase;
Liver;
Platelet Count*;
Pre-Eclampsia;
Pregnancy;
Uric Acid
- From:Korean Journal of Obstetrics and Gynecology
2004;47(3):523-530
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: To determine the incidence of HELLP (hemolysis, elevated liver enzymes and low platelet count) syndrome and assess the relationship between the maternal-fetal complications and the severity of HELLP syndrome, classified based on platelet count nadir. METHODS: We reviewed the maternal and neonatal charts of ten pregnancies complicated by HELLP syndrome, managed at Dankook University Hospital between January, 1995 and December, 2002. Women were divided into 2 groups as class I HELLP which had a maternal platelet nadir 50,000 and 100,000/mm3. We compared the maternal and fetal complications between class I and class II HELLP syndrome. But we did not analyze statistically due to small number of patients. RESULTS: There were four cases of class I HELLP and six cases of class II HELLP syndrome. The incidence of HELLP syndrome was 0.10% (10/10,238) in total deliveries and was 2.26% (10/443) in women with severe pre-eclampsia or eclampsia. The mean level of platelet counts nadir was 41,500/mm3 in class I and 64,000/mm3 in class II HELLP. The mean platelet recovery days (more than 100,000/mm3) were 6.0 and 4.2 days in each class. The mean values of the maximal aspartate aminotransferase (AST/SGOT), alanine aminotransferase (ALT/SGPT) and uric acid might show no differences, but there might be difference in lactate dehydrogenase (LDH) levels which were 5854 and 1388 IU/L in each class. All patients with class I HELLP syndrome showed maternal complications, but only one patient with class II HELLP showed maternal complications. There might be no differences in the mean gestational ages and birth weights. The neonatal complications were similar in each class. CONCLUSION: Our data suggest that patients with class I HELLP syndrome may be at increased risk for serious maternal complications, but the neonatal complications may be associated with gestational ages.
